December 23, 2025
1 min read

AstraZeneca, betting on radiopharmaceuticals, extends Niowave isotope supply deal by 10 years

Pharma giant AstraZeneca extended its supply deal with Michigan-based medical radioisotope producer Niowave by 10 years, teeing up the delivery of Actinium-225 that has shown promise as a component in targeted cancer therapy.

Leave a Reply

Your email address will not be published.

Previous Story

NOVUS Raises the Bar for Animal Nutrition in Mexico

Next Story

How testosterone fell out of favor in medicine — and how it came back

Previous Story

NOVUS Raises the Bar for Animal Nutrition in Mexico

Next Story

How testosterone fell out of favor in medicine — and how it came back

Latest from Blog

Go toTop